Table of Contents Table of Contents
Previous Page  578 / 1173 Next Page
Information
Show Menu
Previous Page 578 / 1173 Next Page
Page Background

ARCON

A

ccelerated

R

adiotherapy +

C

arbOgen +

N

icotinamide

D

D

D

D

D

S S

S S

S

S

S

S S

S

S

S

S

S

S

S

S

S

S

S

S

D

D

D

D D

D D

D

D

S

S

S

S

S

S

S

S

S S

S

S S

S

S

Tumor cell proliferation

D

S

S

S

S

S

S

S

S

D

D

D

D

D

D

D

D

D D

D

S

S S

S

S

S

S

S

S

S

S

S

S

S

S

D

D

D

D

D

D

D

D

D

D

S

S

S S

S

S

S

S

S

S

S

S

S

S

S

S

S

S

S

S

S

S

S

S

D

D

D

D

D

D

D

D

D

D

D

D

S

S

S S

S

S

S

S

S

S

D

D

D

D

D

D

D D

D

D

D

D

D

S

S

S

S

S

S S

S

S

S

S

S

S

S

S S

S

D S

S

D

D

S

S S

S S

S

S

S

D

D

D

S

S

S

S

D

D

D

D

D

S

S

S

S

S

S

S

S

S

S

S

S

S

S

S

Accelerated fractionation

S

D S

S

D

D

S

S S

S S

S

S

S

D

D

D

S

S

S

S

D

D

D

D

D

S

S

S

S

S

S

S

S S

S

S

S

S

S

S

S

D

stem cell

differentiated cell

Chronic hypoxia

Carbogen

98% O

2

+ 2% CO

2

Nicotinamide

Acute hypoxia